1. Academic Validation
  2. Corosolic acid sensitizes ferroptosis by upregulating HERPUD1 in liver cancer cells

Corosolic acid sensitizes ferroptosis by upregulating HERPUD1 in liver cancer cells

  • Cell Death Discov. 2022 Aug 29;8(1):376. doi: 10.1038/s41420-022-01169-0.
Yingxiu Peng 1 Ning Li 2 Feifeng Tang 1 Chunmei Qian 2 Tingting Jia 1 Jingjin Liu 1 Yanfeng Xu 3
Affiliations

Affiliations

  • 1 Department of Pharmacy, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071, Shanghai, China.
  • 2 Central Laboratory, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071, Shanghai, China.
  • 3 Department of Pharmacy, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 200071, Shanghai, China. yf_xu@126.com.
Abstract

Primary liver Cancer is the third leading cause of Cancer death in the world, and the lack of effective treatments is the main reason for the high mortality. Corosolic acid (CA) has been proved to have antitumor activity. In this study, we found that CA can sensitize liver Cancer cells to Ferroptosis, which is a regulated form of cell death characterized by iron-dependent lipid peroxides reaching lethal levels. Here, we revealed that CA can inhibit glutathione (GSH) synthesis via HERPUD1, decreasing the cellular GSH level and causing liver Cancer cells to become more sensitive to Ferroptosis. Mechanistically, further studies found that HERPUD1 reduced the ubiquitination of the GSS-associated E3 ubiquitin ligase MDM2, which promoted ubiquitination of GSS, thereby inhibiting GSH synthesis to increase Ferroptosis susceptibility. Importantly, a mouse xenograft model also demonstrated that CA inhibits tumor growth via HERPUD1. Collectively, our findings suggesting that CA is a candidate component for the development of treatments against liver Cancer.

Figures
Products